Comparison of mitral regurgitation severity assessments based on magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 10 2021
Historique:
received: 17 03 2021
accepted: 27 09 2021
entrez: 7 10 2021
pubmed: 8 10 2021
medline: 29 12 2021
Statut: epublish

Résumé

Mitral regurgitation (MR), which is one of the factors responsible for heart failure symptoms and the development of atrial fibrillation, is an important feature of hypertrophic cardiomyopathy (HCM), and its presence affects which treatment options are chosen. Although cardiac magnetic resonance imaging (MRI) is considered the reference standard for assessing the regurgitant volume (RV) and fraction (RF), echocardiography is the most common method for assessing MR severity. Accordingly, the aim of this study was to compare the results of echocardiography and cardiac MRI for assessing MR severity in a cohort of patients with HCM. MR severity was assessed in 53 patients using cardiac MRI by determining the mitral RV (MRV) and mitral RF (MRF). The results were graded according to thresholds recommended in current guidelines. MR severity assessed by echocardiography was graded by integrating indices of severity. Greater than mild MR, as assessed using echocardiography, was present in 22 patients (41.5%) with HCM and in none of the control patients (p = 0.001). In all, 31 patients (58.5%) had no more than mild MR. When MR severity was assessed using different methods, either moderate (kappa = 0.44, 95% confidence interval = 0.21-0.67), poor or no agreement was found between MRI-derived and echocardiography-derived grades. HCM patients with echocardiography-derived moderate and severe MR had similar median MRVs and MRFs (p = 0.59 and p = 0.11, respectively). In HCM patients, cardiac MRI and echocardiography were at most in modest agreement in assessing MR severity. Importantly, echocardiography-derived moderate and severe MR were not distinguishable by either MRV or MRF.

Identifiants

pubmed: 34615936
doi: 10.1038/s41598-021-99446-y
pii: 10.1038/s41598-021-99446-y
pmc: PMC8494871
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19902

Informations de copyright

© 2021. The Author(s).

Références

J Am Soc Echocardiogr. 2005 Oct;18(10):1074-82
pubmed: 16198885
J Am Coll Cardiol. 2015 Mar 24;65(11):1078-88
pubmed: 25790878
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Kardiol Pol. 2012;70(8):782-8
pubmed: 22933209
J Cardiovasc Magn Reson. 2006;8(3):503-7
pubmed: 16755839
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Am J Cardiol. 2015 Feb 15;115(4):493-8
pubmed: 25541323
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
Circulation. 2012 Oct 16;126(16):2005-17
pubmed: 23071176
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611-44
pubmed: 23733442
Am J Cardiol. 2012 Oct 1;110(7):1015-20
pubmed: 22727180
Sci Rep. 2018 Jul 3;8(1):9995
pubmed: 29968754
Eur Radiol. 2021 Mar;31(3):1194-1205
pubmed: 32876838
Eur J Echocardiogr. 2009 May;10(3):350-6
pubmed: 19246500
Am J Cardiol. 2016 Jan 15;117(2):264-70
pubmed: 26684513
PLoS One. 2020 Jan 13;15(1):e0227012
pubmed: 31929538
Clin Radiol. 2017 Apr;72(4):286-292
pubmed: 28069158
Circ Cardiovasc Imaging. 2010 Nov;3(6):694-700
pubmed: 20810848
J Am Coll Cardiol. 2016 Oct 4;68(14):1497-504
pubmed: 27687190
Radiology. 2012 Oct;265(1):78-86
pubmed: 22771877
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):48-57
pubmed: 23212272
Eur J Echocardiogr. 2010 May;11(4):307-32
pubmed: 20435783
Circulation. 2021 Feb 2;143(5):e35-e71
pubmed: 33332149
Circulation. 2018 Mar 27;137(13):1349-1360
pubmed: 29269390
Sci Rep. 2020 Mar 13;10(1):4707
pubmed: 32170130
Heart. 2016 Dec 1;102(23):1864-1870
pubmed: 27733535
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):125-33
pubmed: 23223636
Circulation. 2020 Dec 22;142(25):e533-e557
pubmed: 33215938
J Cardiovasc Magn Reson. 2017 Dec 21;19(1):105
pubmed: 29268761
Circulation. 2017 Jun 20;135(25):e1159-e1195
pubmed: 28298458
J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60
pubmed: 22075469
Rev Esp Cardiol. 2003 Dec;56(12):1174-81
pubmed: 14670269

Auteurs

Mateusz Śpiewak (M)

Magnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland. mspiewak@ikard.pl.

Mariusz Kłopotowski (M)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland.

Ewa Kowalik (E)

Department of Congenital Heart Diseases, National Institute of Cardiology, Warsaw, Poland.

Łukasz Mazurkiewicz (Ł)

Department of Cardiomyopathies, National Institute of Cardiology, Warsaw, Poland.

Katarzyna Kożuch (K)

Department of Congenital Heart Diseases, National Institute of Cardiology, Warsaw, Poland.

Joanna Petryka-Mazurkiewicz (J)

Department of Coronary Artery Disease and Structural Heart Diseases, National Institute of Cardiology, Warsaw, Poland.

Barbara Miłosz-Wieczorek (B)

Magnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland.

Adam Witkowski (A)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland.

Anna Klisiewicz (A)

Department of Congenital Heart Diseases, National Institute of Cardiology, Warsaw, Poland.

Magdalena Marczak (M)

Magnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH